Fortress Biotech Announces Closing of $10.0 Million Public Offering

Nov 14, 2023

Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Nov 13, 2023

Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Nov 13, 2023

Fortress Biotech Announces Pricing of $10.0 Million Public Offering

Nov 10, 2023

Fortress Biotech Announces Launch of Proposed Public Offering

Nov 09, 2023

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Nov 07, 2023

Avenue Therapeutics Announces Closing of $5.0 Million Public Offering

Nov 02, 2023

Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting

Nov 02, 2023

Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering

Oct 31, 2023

Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

Oct 31, 2023